Artal Group S.A. Spdr Ser Tr Spdr S&P Biotech E Transaction History

Artal Group S.A.

$214 Million
Q3 2024

A detailed history of Artal Group S.A. transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Artal Group S.A. holds 250,000 shares of XBI stock, worth $22.5 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares

250,000

Holding current value

$22.5 Million

% of portfolio

1.28%

0 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form

No transaction found.

Others Institutions Holding XBI

# of Institutions

927

Shares Held

101M

Call Options Held

28.4M

Put Options Held

33.4M

Goldman Sachs Group Inc New York, NY

12.7M
Shares

$1.15 Billion
0.21% of portfolio
Jpmorgan Chase & CO New York, NY

12.3M
Shares

$1.1 Billion
0.1% of portfolio
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6

9.23M
Shares

$830 Million
2.24% of portfolio
Morgan Stanley New York, NY

8.02M
Shares

$721 Million
0.06% of portfolio
Citigroup Inc

7.75M
Shares

$697 Million
0.45% of portfolio

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.

Account